跳至主要内容
临床试验/NCT00179192
NCT00179192撤回2 期

Prevention and Treatment of Hemodialysis Vascular Access Malfunction

Vanderbilt University2 个研究点 分布在 1 个国家开始时间: 1998年5月最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
试验地点
2
主要终点
To test the hypothesis that early intervention of a vascular access determined to be at increased risk of malfunction and thrombosis improves the long-term access outcome versus standard of care.

研究概览

简要总结

Vascular access is considered the Achilles heel of the dialysis patient. It constitutes the largest single cause of morbidity in the chronic hemodialysis population, accounting for over 25% of hospitalizations at an estimated cost in the US of at least one billion dollars annually. Currently, complication free survival of vascular access ranges between 30-50% a year and multiple investigative efforts in this area have been initiated and are directed at prolonging the functional life of vascular accesses.

It is not well established whether intervention prior to overt malfunction or thrombosis of the vascular access could reduce these complications and thereby improve the functional longevity of the access. Moreover, once accesses at potential risk are identified, it is not well established which method of intervention, Surgery vs. Angioplasty vs. Expectant Management, is superior in terms of clinical and financial outcome. The proposed study aims to determine whether early intervention of a vascular access determined to be at risk of malfunction and thrombosis improves the long term outcome and, specifically, which means of intervention is preferred.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with End Stage Renal Disease on chronic maintenance hemodialysis 3 times per week
  • Have an arteriovenous (polytetrafluoroethylene) graft as vascular access
  • Have a venous stenosis between 30% and 70% as determined by angiogram

排除标准

  • Native arteriovenous fistula
  • Known previous vascular accesses complications, such as central vein stenosis, and multiple access surgeries >4
  • Unwilling to participate
  • Allergy to iodine
  • Absolute contraindication for surgery (e.g. medical condition precludes anesthesia and surgery)
  • Known arterial limb stenosis or long vessel length venous stenosis which are unamenable to surgical or angioplasty techniques, respectively, and therefore prohibit randomization
  • Known hypercoagulable state

结局指标

主要结局

To test the hypothesis that early intervention of a vascular access determined to be at increased risk of malfunction and thrombosis improves the long-term access outcome versus standard of care.

时间窗: 2 years

次要结局

  • To determine which means of early intervention, surgery versus angioplasty, is medically and financially advantageous.(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alp Ikizler

Professor

Vanderbilt University

研究点 (2)

Loading locations...

相似试验